← Browse by Condition
Medical Condition
metabolic syndrome
Total Trials
6
Recruiting Now
6
Trial Phases
EARLY_Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for metabolic syndrome sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — metabolic syndrome Clinical Trials
How many clinical trials are currently recruiting for metabolic syndrome?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for metabolic syndrome, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for metabolic syndrome?
metabolic syndrome research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a metabolic syndrome clinical trial?
Eligibility criteria for metabolic syndrome trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT04634591
Recruiting
The Bialystok Bariatric Surgery Study
Enrollment
1,000 pts
Location
Poland
Sponsor
Medical University of Bialysto...
NCT05802121 EARLY_Phase 1
Recruiting
Akkermansia Muciniphilia and Metabolic Side Effects of ADT
Enrollment
30 pts
Location
Canada
Sponsor
Western University
NCT07410325
Recruiting
Effectiveness and Implementation of a Community-based Health Coach-led Artificial Intelligence (AI)-Powered Digital Self-Regulation Program for Individuals With Metabolic Syndrome (MetS)
Enrollment
316 pts
Location
Singapore
Sponsor
National University Health Sys...
NCT06377254
Recruiting
Multi-organ Responses to CHronic Physical Activity and INactivity
Enrollment
40 pts
Location
United Kingdom
Sponsor
University of Nottingham
NCT06144593
Recruiting
The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes
Enrollment
14 pts
Location
Denmark
Sponsor
Hvidovre University Hospital
NCT06061926 Phase 2
Recruiting
Effect of Celery Seed on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
Enrollment
28 pts
Location
Mexico
Sponsor
University of Guadalajara
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology